Note: Ingredients listed on restricted chemical lists
EC/CAS
110-54-3
Name of the chemical
n-Hexan (790/2009)
Concentration
N/A
General Information
Revision date
2006-01-17
Product name
n-Butyllithium
Chemical name
n-Butyllithium
CAS No.
109-72-8
supplier name
TCI America
Icons in SDS
Company Information
company name
TCI America
Section 2
Potential Acute Health Effects
Corrosive to skin, eyes, and respiratory system. Liquid or spray mist may produce tissue damage, particularly in mucous membranes of the eyes, mouth and respiratory tract. Skin contact may produce burns. Eye contact can result in corneal damage or blindness. Inhalation of the spray mist may produce severe irritation of respiratory tract, characterized by coughing, choking, or shortness of breath. Corrosive materials may cause serious injury if ingested. Follow safe industrial hygiene practices and always wear proper protective equipment when handling this compound.
Potential chronic health
CARCINOGENIC EFFECTS : Not available. MUTAGENIC EFFECTS : Not available.
Teratogenic Effects
TUMORIGENIC EFFECTS Hexane: Rat TCLo (inhalation) 1000ppm/4 Hours/59 Weeks, intermittent. Toxic Effects: Tumorigenic- Carcinogenic by RTECS criteria. Tumorigenic Effects- Testicular tumors. Mouse TCLo (inhalation) 9018ppm/6 Hours/2 Years, intermittent. Toxic Effects: Tumorigenic- Neoplastic by RTECS criteria. Liver- Tumors. DEVELOPMENTAL TOXICITY : REPRODUCTIVE EFFECTS: Hexane: Rat TCLo (inhalation) 5000ppm/20 Hours, female, 6-19 Days of pregnancy. Toxic Effects: Effects on Embryo or Fetus- Fetotoxicity. Rat TCLo (inhalation) 1000ppm/6 Hours, female, 8-16 Days of pregnancy. Toxic Effects: Effects on Newborn- Growth statistics. Mouse TDLo (oral) 238gm/kg, female, 6-15 Days of pregnancy. Toxic Effects: Effects on Embryo or Fetus- Fetotoxicity. Repeated or prolonged contact with spray mist may produce chronic eye irritation and severe skin irritation. Repeated or prolonged exposure to spray mist may produce respiratory tract irritation leading to frequent attacks of bronchial infection. (ca 15% in Hexane) Section IV.